1. Home
  2. VYNE vs CRWS Comparison

VYNE vs CRWS Comparison

Compare VYNE & CRWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • CRWS
  • Stock Information
  • Founded
  • VYNE 2003
  • CRWS 1957
  • Country
  • VYNE United States
  • CRWS United States
  • Employees
  • VYNE N/A
  • CRWS N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • CRWS Textiles
  • Sector
  • VYNE Health Care
  • CRWS Consumer Discretionary
  • Exchange
  • VYNE Nasdaq
  • CRWS Nasdaq
  • Market Cap
  • VYNE 41.9M
  • CRWS 48.2M
  • IPO Year
  • VYNE 2018
  • CRWS N/A
  • Fundamental
  • Price
  • VYNE $2.49
  • CRWS $4.55
  • Analyst Decision
  • VYNE Strong Buy
  • CRWS
  • Analyst Count
  • VYNE 2
  • CRWS 0
  • Target Price
  • VYNE $6.88
  • CRWS N/A
  • AVG Volume (30 Days)
  • VYNE 70.8K
  • CRWS 17.5K
  • Earning Date
  • VYNE 11-07-2024
  • CRWS 02-12-2025
  • Dividend Yield
  • VYNE N/A
  • CRWS 7.03%
  • EPS Growth
  • VYNE N/A
  • CRWS N/A
  • EPS
  • VYNE N/A
  • CRWS 0.32
  • Revenue
  • VYNE $493,000.00
  • CRWS $87,052,000.00
  • Revenue This Year
  • VYNE $28.30
  • CRWS N/A
  • Revenue Next Year
  • VYNE N/A
  • CRWS N/A
  • P/E Ratio
  • VYNE N/A
  • CRWS $14.43
  • Revenue Growth
  • VYNE 39.27
  • CRWS 6.33
  • 52 Week Low
  • VYNE $1.57
  • CRWS $4.21
  • 52 Week High
  • VYNE $3.43
  • CRWS $5.97
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 40.82
  • CRWS 49.16
  • Support Level
  • VYNE $2.34
  • CRWS $4.40
  • Resistance Level
  • VYNE $2.69
  • CRWS $4.57
  • Average True Range (ATR)
  • VYNE 0.19
  • CRWS 0.07
  • MACD
  • VYNE -0.04
  • CRWS -0.00
  • Stochastic Oscillator
  • VYNE 13.79
  • CRWS 51.72

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

Share on Social Networks: